▶ 調査レポート

クローン病治療薬の世界市場レポート2020

• 英文タイトル:Global Crohn's Disease Drug Sales Market Report 2020

が調査・発行した産業分析レポートです。クローン病治療薬の世界市場レポート2020 / Global Crohn's Disease Drug Sales Market Report 2020 / MRC2102QY3691資料のイメージです。• レポートコード:MRC2102QY3691
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥600,000 (USD4,000)▷ お問い合わせ
  Multi User¥900,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,200,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のクローン病治療薬市場について種類別(アミノサリチル酸、コルチコステロイド、免疫調節剤、抗生物質)、用途別(疼痛緩和(無症状性)、減量維持(再発防止)、小児クローン病)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・クローン病治療薬市場の概要
・世界の主要地域別クローン病治療薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のクローン病治療薬市場規模2015-2026:種類別(アミノサリチル酸、コルチコステロイド、免疫調節剤、抗生物質)
・世界のクローン病治療薬市場規模2015-2026:用途別(疼痛緩和(無症状性)、減量維持(再発防止)、小児クローン病)
・クローン病治療薬の米国市場規模2015-2020
・クローン病治療薬のヨーロッパ市場規模2015-2020
・クローン病治療薬の中国市場規模2015-2020
・クローン病治療薬の日本市場規模2015-2020
・クローン病治療薬の東南アジア市場規模2015-2020
・クローン病治療薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・クローン病治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・クローン病治療薬の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Crohn’s Disease Drug Market
The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Crohn’s Disease Drug Scope and Market Size
The global Crohn’s Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Crohn’s Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Crohn’s Disease Drug market is segmented into
Aminosalicylates
Corticosteroids
Immunomodulators
Antibiotics

Segment by Application, the Crohn’s Disease Drug market is segmented into
Achieving Remission (The Absence Of Symptoms)
Maintaining Remission (Prevention Of Flare-Ups)
Pediatric Crohn’S Disease

The Crohn’s Disease Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Crohn’s Disease Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Crohn’s Disease Drug Market Share Analysis
Crohn’s Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Crohn’s Disease Drug business, the date to enter into the Crohn’s Disease Drug market, Crohn’s Disease Drug product introduction, recent developments, etc.

The major vendors covered:
AbbVie
Janssen Biotech
Takeda Pharmaceuticals
UCB
Amgen
Tillotts Pharma

レポート目次

1 Crohn’s Disease Drug Market Overview
1.1 Crohn’s Disease Drug Product Scope
1.2 Crohn’s Disease Drug Segment by Type
1.2.1 Global Crohn’s Disease Drug Sales by Type (2020-2026)
1.2.2 Aminosalicylates
1.2.3 Corticosteroids
1.2.4 Immunomodulators
1.2.5 Antibiotics
1.3 Crohn’s Disease Drug Segment by Application
1.3.1 Global Crohn’s Disease Drug Sales Comparison by Application (2020-2026)
1.3.2 Achieving Remission (The Absence Of Symptoms)
1.3.3 Maintaining Remission (Prevention Of Flare-Ups)
1.3.4 Pediatric Crohn’S Disease
1.4 Crohn’s Disease Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Crohn’s Disease Drug Sales Growth Rate (2015-2026)
1.4.2 Global Crohn’s Disease Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Crohn’s Disease Drug Price Trends (2015-2026)

2 Crohn’s Disease Drug Estimate and Forecast by Region
2.1 Global Crohn’s Disease Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Crohn’s Disease Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Crohn’s Disease Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Crohn’s Disease Drug Revenue Market Share by Region (2015-2020)
2.3 Global Crohn’s Disease Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Crohn’s Disease Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Crohn’s Disease Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Crohn’s Disease Drug Estimates and Projections (2015-2026)
2.4.2 Europe Crohn’s Disease Drug Estimates and Projections (2015-2026)
2.4.3 China Crohn’s Disease Drug Estimates and Projections (2015-2026)
2.4.4 Japan Crohn’s Disease Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Crohn’s Disease Drug Estimates and Projections (2015-2026)
2.4.6 India Crohn’s Disease Drug Estimates and Projections (2015-2026)
3 Global Crohn’s Disease Drug Competition Landscape by Players
3.1 Global Top Crohn’s Disease Drug Players by Sales (2015-2020)
3.2 Global Top Crohn’s Disease Drug Players by Revenue (2015-2020)
3.3 Global Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Drug as of 2019)
3.4 Global Crohn’s Disease Drug Average Price by Company (2015-2020)
3.5 Manufacturers Crohn’s Disease Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Crohn’s Disease Drug Players (Opinion Leaders)
4 Global Crohn’s Disease Drug Market Size by Type
4.1 Global Crohn’s Disease Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Crohn’s Disease Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Crohn’s Disease Drug Price by Type (2015-2020)
4.2 Global Crohn’s Disease Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Crohn’s Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Crohn’s Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Crohn’s Disease Drug Price Forecast by Type (2021-2026)
5 Global Crohn’s Disease Drug Market Size by Application
5.1 Global Crohn’s Disease Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Crohn’s Disease Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Crohn’s Disease Drug Price by Application (2015-2020)
5.2 Global Crohn’s Disease Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Crohn’s Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Crohn’s Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Crohn’s Disease Drug Price Forecast by Application (2021-2026)

6 United States Crohn’s Disease Drug Market Facts & Figures
6.1 United States Crohn’s Disease Drug Sales Market Share by Company (2015-2020)
6.2 United States Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
6.3 United States Crohn’s Disease Drug Sales Market Share by Application (2015-2020)

7 Europe Crohn’s Disease Drug Market Facts & Figures
7.1 Europe Crohn’s Disease Drug Sales Market Share by Company (2015-2020)
7.2 Europe Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
7.3 Europe Crohn’s Disease Drug Sales Market Share by Application (2015-2020)

8 China Crohn’s Disease Drug Market Facts & Figures
8.1 China Crohn’s Disease Drug Sales Market Share by Company (2015-2020)
8.2 China Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
8.3 China Crohn’s Disease Drug Sales Market Share by Application (2015-2020)

9 Japan Crohn’s Disease Drug Market Facts & Figures
9.1 Japan Crohn’s Disease Drug Sales Market Share by Company (3015-3030)
9.2 Japan Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
9.3 Japan Crohn’s Disease Drug Sales Market Share by Application (2015-2020)

10 Southeast Asia Crohn’s Disease Drug Market Facts & Figures
10.1 Southeast Asia Crohn’s Disease Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Crohn’s Disease Drug Sales Market Share by Application (2015-2020)

11 India Crohn’s Disease Drug Market Facts & Figures
11.1 India Crohn’s Disease Drug Sales Market Share by Company (2015-2020)
11.2 India Crohn’s Disease Drug Sales Market Share by Type (2015-2020)
11.3 India Crohn’s Disease Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Crohn’s Disease Drug Business
12.1 AbbVie
12.1.1 AbbVie Corporation Information
12.1.2 AbbVie Business Overview
12.1.3 AbbVie Crohn’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Crohn’s Disease Drug Products Offered
12.1.5 AbbVie Recent Development
12.2 Janssen Biotech
12.2.1 Janssen Biotech Corporation Information
12.2.2 Janssen Biotech Business Overview
12.2.3 Janssen Biotech Crohn’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Janssen Biotech Crohn’s Disease Drug Products Offered
12.2.5 Janssen Biotech Recent Development
12.3 Takeda Pharmaceuticals
12.3.1 Takeda Pharmaceuticals Corporation Information
12.3.2 Takeda Pharmaceuticals Business Overview
12.3.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Takeda Pharmaceuticals Crohn’s Disease Drug Products Offered
12.3.5 Takeda Pharmaceuticals Recent Development
12.4 UCB
12.4.1 UCB Corporation Information
12.4.2 UCB Business Overview
12.4.3 UCB Crohn’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 UCB Crohn’s Disease Drug Products Offered
12.4.5 UCB Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Business Overview
12.5.3 Amgen Crohn’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen Crohn’s Disease Drug Products Offered
12.5.5 Amgen Recent Development
12.6 Tillotts Pharma
12.6.1 Tillotts Pharma Corporation Information
12.6.2 Tillotts Pharma Business Overview
12.6.3 Tillotts Pharma Crohn’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Tillotts Pharma Crohn’s Disease Drug Products Offered
12.6.5 Tillotts Pharma Recent Development

13 Crohn’s Disease Drug Manufacturing Cost Analysis
13.1 Crohn’s Disease Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Crohn’s Disease Drug
13.4 Crohn’s Disease Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Crohn’s Disease Drug Distributors List
14.3 Crohn’s Disease Drug Customers

15 Market Dynamics
15.1 Crohn’s Disease Drug Market Trends
15.2 Crohn’s Disease Drug Opportunities and Drivers
15.3 Crohn’s Disease Drug Market Challenges
15.4 Crohn’s Disease Drug Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Crohn's Disease Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Crohn's Disease Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Crohn's Disease Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Crohn's Disease Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Crohn's Disease Drug Sales Market Share by Region (2015-2020)
Table 6. Global Crohn's Disease Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Crohn's Disease Drug Revenue Share by Region (2015-2020)
Table 8. Global Crohn's Disease Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Crohn's Disease Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Crohn's Disease Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Crohn's Disease Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Crohn's Disease Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Crohn's Disease Drug Sales Share by Company (2015-2020)
Table 14. Global Crohn's Disease Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Crohn's Disease Drug Revenue Share by Company (2015-2020)
Table 16. Global Crohn's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease Drug as of 2019)
Table 17. Global Crohn's Disease Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Crohn's Disease Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Crohn's Disease Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Crohn's Disease Drug Players
Table 22. Global Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Crohn's Disease Drug Sales Share by Type (2015-2020)
Table 24. Global Crohn's Disease Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Crohn's Disease Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Crohn's Disease Drug Sales Share by Type (2021-2026)
Table 27. Global Crohn's Disease Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Crohn's Disease Drug Revenue Share by Type (2021-2026)
Table 29. Global Crohn's Disease Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Crohn's Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Crohn's Disease Drug Sales Share by Application (2015-2020)
Table 32. Global Crohn's Disease Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Crohn's Disease Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Crohn's Disease Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Crohn's Disease Drug Sales Share by Application (2021-2026)
Table 36. Global Crohn's Disease Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Crohn's Disease Drug Revenue Share by Application (2021-2026)
Table 38. Global Crohn's Disease Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Crohn's Disease Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Crohn's Disease Drug Sales Market Share by Company (2015-2020)
Table 41. United States Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Crohn's Disease Drug Sales Market Share by Type (2015-2020)
Table 43. United States Crohn's Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Crohn's Disease Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Crohn's Disease Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Crohn's Disease Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Crohn's Disease Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Crohn's Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Crohn's Disease Drug Sales Market Share by Type (2015-2020)
Table 51. China Crohn's Disease Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Crohn's Disease Drug Sales Market Share by Company (2015-2020)
Table 53. China Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Crohn's Disease Drug Sales Market Share by Type (2015-2020)
Table 55. China Crohn's Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Crohn's Disease Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Crohn's Disease Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Crohn's Disease Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Crohn's Disease Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Crohn's Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Crohn's Disease Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Crohn's Disease Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Crohn's Disease Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Crohn's Disease Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Crohn's Disease Drug Sales Market Share by Application (2015-2020)
Table 69. India Crohn's Disease Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Crohn's Disease Drug Sales Market Share by Company (2015-2020)
Table 71. India Crohn's Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Crohn's Disease Drug Sales Market Share by Type (2015-2020)
Table 73. India Crohn's Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Crohn's Disease Drug Sales Market Share by Application (2015-2020)
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Crohn's Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AbbVie Crohn's Disease Drug Product
Table 79. AbbVie Recent Development
Table 80. Janssen Biotech Corporation Information
Table 81. Janssen Biotech Description and Business Overview
Table 82. Janssen Biotech Crohn's Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Janssen Biotech Crohn's Disease Drug Product
Table 84. Janssen Biotech Recent Development
Table 85. Takeda Pharmaceuticals Corporation Information
Table 86. Takeda Pharmaceuticals Description and Business Overview
Table 87. Takeda Pharmaceuticals Crohn's Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Takeda Pharmaceuticals Crohn's Disease Drug Product
Table 89. Takeda Pharmaceuticals Recent Development
Table 90. UCB Corporation Information
Table 91. UCB Description and Business Overview
Table 92. UCB Crohn's Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. UCB Crohn's Disease Drug Product
Table 94. UCB Recent Development
Table 95. Amgen Corporation Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Crohn's Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Amgen Crohn's Disease Drug Product
Table 99. Amgen Recent Development
Table 100. Tillotts Pharma Corporation Information
Table 101. Tillotts Pharma Description and Business Overview
Table 102. Tillotts Pharma Crohn's Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Tillotts Pharma Crohn's Disease Drug Product
Table 104. Tillotts Pharma Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Crohn's Disease Drug Distributors List
Table 108. Crohn's Disease Drug Customers List
Table 109. Crohn's Disease Drug Market Key Trends
Table 110. Crohn's Disease Drug Key Opportunities and Drivers
Table 111. Crohn's Disease Drug Market Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Crohn's Disease Drug Product Picture
Figure 2. Global Crohn's Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Crohn's Disease Drug Market Share by Application in 2020 & 2026
Figure 6. Achieving Remission (The Absence Of Symptoms) Examples
Figure 7. Maintaining Remission (Prevention Of Flare-Ups) Examples
Figure 8. Pediatric Crohn'S Disease Examples
Figure 9. Global Crohn's Disease Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Crohn's Disease Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Crohn's Disease Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Crohn's Disease Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Crohn's Disease Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Crohn's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Crohn's Disease Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Crohn's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Crohn's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Crohn's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Crohn's Disease Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Crohn's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Crohn's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Crohn's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Crohn's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Crohn's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Crohn's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Crohn's Disease Drug Players Market Share by Revenue in Crohn's Disease Drug 2015 & 2019
Figure 27. Crohn's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Crohn's Disease Drug Revenue Share by Type (2015-2020)
Figure 29. Global Crohn's Disease Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Crohn's Disease Drug Revenue Share by Application (2015-2020)
Figure 31. Global Crohn's Disease Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Crohn's Disease Drug Sales Market Share by Type in 2019
Figure 33. United States Crohn's Disease Drug Sales Market Share by Type in 2019
Figure 34. Europe Crohn's Disease Drug Sales Market Share by Company in 2019
Figure 35. Europe Crohn's Disease Drug Sales Market Share by Type in 2019
Figure 36. Europe Crohn's Disease Drug Sales Market Share by Application in 2019
Figure 37. China Crohn's Disease Drug Sales Market Share by Company in 2019
Figure 38. China Crohn's Disease Drug Sales Market Share by Type in 2019
Figure 39. China Crohn's Disease Drug Sales Market Share by Application in 2019
Figure 40. Japan Crohn's Disease Drug Sales Market Share by Company in 2019
Figure 41. Japan Crohn's Disease Drug Sales Market Share by Type in 2019
Figure 42. Japan Crohn's Disease Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Crohn's Disease Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Crohn's Disease Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Crohn's Disease Drug Sales Market Share by Application in 2019
Figure 46. India Crohn's Disease Drug Sales Market Share by Company in 2019
Figure 47. India Crohn's Disease Drug Sales Market Share by Type in 2019
Figure 48. India Crohn's Disease Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Crohn's Disease Drug
Figure 51. Manufacturing Process Analysis of Crohn's Disease Drug
Figure 52. Crohn's Disease Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed